tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

APGE Stock Latest News

Apogee Therapeutics initiated with a Buy at Citi
The FlyApogee Therapeutics initiated with a Buy at Citi
18d ago
APGE
Strong Buy Recommendation for Apogee Therapeutics Driven by Promising Clinical Data and Strategic Pipeline Developments
PremiumRatings
Strong Buy Recommendation for Apogee Therapeutics Driven by Promising Clinical Data and Strategic Pipeline Developments
20d ago
APGE
Apogee Therapeutics: Buy Rating Backed by Promising Data and Strong Financial Position
PremiumRatings
Apogee Therapeutics: Buy Rating Backed by Promising Data and Strong Financial Position
26d ago
APGE
Optimistic Buy Rating for Apogee Therapeutics Driven by Promising Clinical Trial Developments
PremiumRatings
Optimistic Buy Rating for Apogee Therapeutics Driven by Promising Clinical Trial Developments
26d ago
APGE
Apogee Therapeutics Reports 2024 Financial Results and Pipeline Progress
PremiumCompany Announcements
Apogee Therapeutics Reports 2024 Financial Results and Pipeline Progress
27d ago
APGE
Apogee Therapeutics price target raised to $116 from $110 at Guggenheim
PremiumThe FlyApogee Therapeutics price target raised to $116 from $110 at Guggenheim
27d ago
APGE
Apogee Therapeutics Reports Positive Phase 1 Results
Premium
Company Announcements
Apogee Therapeutics Reports Positive Phase 1 Results
27d ago
8K
APGE
Apogee Therapeutics says cash sufficient to fund expenses into 1Q28
Premium
The Fly
Apogee Therapeutics says cash sufficient to fund expenses into 1Q28
28d ago
APGE
Apogee Therapeutics announces ‘positive’ results from Phase 1 trial of APG990
PremiumThe Fly
Apogee Therapeutics announces ‘positive’ results from Phase 1 trial of APG990
28d ago
APGE
Buy Rating Affirmed for Apogee Therapeutics: Promising Developments in Inflammatory Disease Treatments
PremiumRatings
Buy Rating Affirmed for Apogee Therapeutics: Promising Developments in Inflammatory Disease Treatments
2M ago
APGE
Oruka Therapeutics initiated with an Outperform at Wolfe Research
PremiumThe Fly
Oruka Therapeutics initiated with an Outperform at Wolfe Research
2M ago
APGE
ORKA
Apogee Therapeutics Advances APG777 in Key Phase 2 Trial
PremiumCompany Announcements
Apogee Therapeutics Advances APG777 in Key Phase 2 Trial
2M ago
8K
APGE
Apogee announces first patient dosed in Part B of Phase 2 APEX trial
PremiumThe FlyApogee announces first patient dosed in Part B of Phase 2 APEX trial
2M ago
APGE
Short Report: Spike in bearish bets on Lovesac pays off
Premium
The Fly
Short Report: Spike in bearish bets on Lovesac pays off
3M ago
GES
HPK
Apogee Therapeutics Advances Clinical Trials for APG333
Premium
Company Announcements
Apogee Therapeutics Advances Clinical Trials for APG333
4M ago
8K
APGE
Apogee Therapeutics first participants dosed in Phase 1 trial of APG333
PremiumThe Fly
Apogee Therapeutics first participants dosed in Phase 1 trial of APG333
4M ago
APGE
Apogee Therapeutics price target raised to $90 from $87 at Wedbush
PremiumThe Fly
Apogee Therapeutics price target raised to $90 from $87 at Wedbush
4M ago
APGE
Apogee Therapeutics Advances in I&I Disease Treatments
PremiumCompany Announcements
Apogee Therapeutics Advances in I&I Disease Treatments
4M ago
8K
APGE
Apogee Therapeutics highlights progress at 2024 Inaugural R&D Day
PremiumThe Fly
Apogee Therapeutics highlights progress at 2024 Inaugural R&D Day
4M ago
APGE
Apogee Therapeutics plans to take combination approach to AD
PremiumThe FlyApogee Therapeutics plans to take combination approach to AD
4M ago
APGE
Apogee Therapeutics price target raised to $110 from $95 at Guggenheim
Premium
The Fly
Apogee Therapeutics price target raised to $110 from $95 at Guggenheim
4M ago
APGE
Apogee initiated with a Buy at Canaccord on APG777 ‘blockbuster potential’
Premium
The Fly
Apogee initiated with a Buy at Canaccord on APG777 ‘blockbuster potential’
4M ago
APGE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >